Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.
| Brand name | VENLAFAXINE |
| Generic name | VENLAFAXINE |
| Active ingredient(s) | VENLAFAXINE HYDROCHLORIDE |
| Distributed by / for | Zydus Pharmaceuticals (USA) Inc |
| NDC | 68382-021-01 |
| Full product label | Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-021-01. |
| Recalling firm | Zydus Pharmaceuticals (USA) Inc |
| Distribution | US Nationwide. |
| Quantity | 13,128 100-Count Bottles |
| Recall initiated | 2025-03-21 |
| Report date | 2025-04-16 |
| Recall completed | — |
| Recall number | D-0310-2025 |
| Classification | Class II |
| FDA status | Completed |
| Origin on file | Pennington NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗